Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

SELL
$194.69 - $268.46 $47,309 - $65,235
-243 Reduced 18.56%
1,066 $285,000
Q2 2022

Aug 02, 2022

BUY
$187.54 - $223.02 $2,062 - $2,453
11 Added 0.85%
1,309 $267,000
Q1 2022

May 10, 2022

BUY
$193.77 - $244.14 $251,513 - $316,893
1,298 New
1,298 $273,000
Q4 2021

Jan 31, 2022

SELL
$223.92 - $287.77 $1.12 Million - $1.44 Million
-5,017 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $1.25 Million - $1.63 Million
4,411 Added 727.89%
5,017 $1.42 Million
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $156,954 - $251,314
606 New
606 $210,000
Q3 2020

Oct 26, 2020

SELL
$264.77 - $305.71 $3.2 Million - $3.69 Million
-12,079 Closed
0 $0
Q2 2020

Jul 21, 2020

BUY
$258.66 - $342.55 $3.12 Million - $4.14 Million
12,079 New
12,079 $3.23 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Steel Peak Wealth Management LLC Portfolio

Follow Steel Peak Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steel Peak Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steel Peak Wealth Management LLC with notifications on news.